|
|
Appointment Type |
Department |
Division |
Rank |
| Primary |
Neurobiology |
Neurobiology |
Assistant Professor |
| Secondary |
Cell, Developmntl, & Integrative Biology |
Cell, Developmntl, & Integrative Biology |
Assistant Professor |
| Center |
Center for Aging |
Center for Aging |
Assistant Professor |
| Center |
Civitan International Research Center |
Civitan International Research Center |
Assistant Professor |
| Center |
Ctr for Glial Bio in Med |
Ctr for Glial Bio in Med |
Assistant Professor |
|
| Cancer Biology |
| Cell, Molecular, & Developmental Biology |
| Neuroscience |
| Pathobiology and Molecular Medicine |
|
| Publication |
PUBMEDID |
| Muhammad AKM, Candolfi M, King GD, Yagiz K, Foulad D, Mineharu Y, Kroeger KM, Treuer KA, Nichols WS, Sandersen NS, Yang J, Khayznikof, M, Van Rooijen N, Lowenstein PR, Castro MG. Antiglioma Immunological Memory in Response to Conditional Cytotoxic/Immune Stimulatory Gene Therapy: Humoral and Cellular Immunity Lead to Tumor Regression. Clinical Cancer Research (2009) 15(19):6113-6127 |
19789315 |
| King GD, Muhammad AKM, Xiong W, Kroeger KM, Puntel M, Larocque D, Palmer D, Ng P, Lowenstein PR, Castro MG. High-capacity adenoviral vector-mediated anti-glioma gene therapy in the presence of systemic anti-adenovirus immunity. Journal of Virology (2008) 82(9):4680-4. |
18287240 |
| King GD, , Kroeger KM, Bresee CJ, Candolfi M, Liu C, Manalo CM, Muhammad AKM, Pechnick RN, Lowenstein PR, Castro MG. Flt3L in combination with HSV1-TK- mediated gene therapy reverses brain tumor-induced behavioral deficits. Molecular Therapy (2008) 16(4):682-90. |
18283279 |
| King GD, Muhammad AKM, CurtinJF, Barcia C, Puntel M, Liu C, Candolfi M, Honig SB, Mondkar S, Lowenstein PR, Castro MG. Flt3L and HSV1-TK eradicate multifocal glioma in a syngeneic glioblastoma model. Neuro-oncology; (2008) 10(1):19-31. |
18079358 |
| Curtin JF, King GD, Barcia C, Liu C, Hubert FX, Guillonneau C, Josien R, Anegon I, Lowenstein PR, Castro MG. Flt3 ligand recruits plasmacytoid dendritic cells to the brain. Journal of Immunology (2006) 176: 3566 – 3577. |
16517725 |
| King GD*, Curtin JF*, Candolfi M, Kroeger K, Lowenstein PR, Castro MG. Gene Therapy and Targeted Toxins for Glioma. Current Gene Therapy (2005) 5:535-557. PMID: |
16457645 |
| Curtin JF*, King GD*, Candolfi M, Greeno RB, Kroeger KM, Lowenstein PR, Castro MG. Combining cytotoxic and immune-mediated gene therapy to treat brain tumors. Current Topics in Medicinal Chemistry (2005) 5(12):1151-70. |
16248789 |
| Ali S*, King GD*, Curtin JF, , Xiong W, Puntel M, Liu C, Cheng Q, Prieto J, Lassmann H, Lowenstein PR, Castro MG. Combined immune-stimulation and conditional cytotoxic gene therapy provide long-term survival in a macroscopic glioma model. Cancer Research, (2005) 65 (16) :7194-204. |
16103070 |
| King GD, Cherian K, Turner RS. X11α impairs γ- but not β-secretase cleavage of Amyloid Precursor Protein. Journal of Neurochemistry, (2005) 88 (4):971-82. |
14756819 |
| King GD, Turner RS. Adaptor protein interactions: modulators of Amyloid Precursor Protein metabolism and Alzheimer’s disease risk? Experimental Neurology. (2004)185: 208-19. |
14736502 |
|
© 2008 University of Alabama at Birmingham. All rights reserved. DisclaimerAbout this SiteGraphic Design Created by UAB Web Communications.
Calendar Designed by Medical Education Information Services. To report problems with the site, email us at meis@uab.edu. Last Revision: February 15, 2012.
The UAB School of Medicine Mailing Address: 1530 3rd Avenue South, FOT 1203, Birmingham AL 35294-3412
|